Development and user-testing of a brief decision aid for aspirin as a preventive approach alongside colorectal cancer screening.

ABSTRACT:

Background

Several epidemiological and cohort studies suggest that regular low-dose aspirin use independently reduces the long-term incidence and risk of colorectal cancer deaths by approximately 20%. However, there are also risks to aspirin use, mainly gastrointestinal bleeding and haemorrhagic stroke. Making informed decisions depends on the ability to understand and weigh up benefits and risks of available options. A decision aid to support people to consider aspirin therapy alongside participation in the NHS bowel cancer screening programme may have an additional impact on colorectal cancer prevention. This study aims to develop and user-test a brief decision aid about aspirin to enable informed decision-making for colorectal screening-eligible members of the public.

Methods

SUBMITTER: Semedo L 

PROVIDER: S-EPMC8139147 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature